Germany, France pay the price for AstraZeneca alarmism as citizens REFUSE Oxford jab

0
16

Germany, France pay the price for their alarmist action on AstraZeneca as citizens REFUSE Oxford coup, further delaying their shambolic vaccination campaigns

  • Thousands of people deliberately skip dates for Oxford jab in Europe
  • Executives had stoked fears that it was ‘near ineffective’, leading to low adoption
  • Germany and France only vaccinated 6% of their population

People in Germany and France are refusing to take the Oxford AstraZeneca vaccine after their executives warn of its effectiveness.

Only 150,000 doses of the 1.5 million vaccine had been used in Germany by Friday, with many deliberately skipping appointments after learning they would receive the Oxford vaccine.

Politicians across Europe, including Emmanuel Macron, have stoked fears the vaccine is ‘near ineffective’ in people over 65, despite minimal data to support it and many health authorities approving its use.

Politicians across Europe, including Emmanuel Macron, have stoked fears the vaccine is 'near ineffective' in people over 65

Politicians across Europe, including Emmanuel Macron, have stoked fears the vaccine is ‘near ineffective’ in people over 65

People in Germany and France refuse to take Oxford AstraZeneca vaccine after executives Macron and Angela Merkel warn of its effectiveness

People in Germany and France refuse to take Oxford AstraZeneca vaccine after executives Macron and Angela Merkel warn of its effectiveness

But leaders are now urging people to take the Oxford shot as the lack of adoption threatens to further derail the vaccination rollout in Europe, which still lags far behind the UK.

Germany and France have only vaccinated six percent of their population, while the UK has distributed doses to more than 26 percent of people.

In Berlin, the Tegel vaccination centers, which only offer AstraZeneca vaccines, say 200 people meet the 3,800 daily appointments, the Times reported.

In France, health workers have also refused the vaccine after Macron said during the heated controversy over its effectiveness.

The European Medicines Agency has approved it for all adults, but Germany has decided that it should not be given to people over 65.

It is only given to healthcare workers and people under 65 with pre-existing conditions.

There are now more and more calls in Europe for the Oxford jab to be given to anyone who wants it so that the vials are not wasted.

Karl Lauterbach, epidemiologist and Social Democratic MP in Germany, said: “The vaccination booths are ready, the vaccine is there, as are the vaccination teams.

“But the vaccine remains unused because there are not enough people coming to the appointment. It is an absurd and unbearable situation.

Berlin Mayor Michael Muller threatened to send people to the bottom of the vaccine queue if they refused Oxford’s coup in favor of Pfizer’s.

In Berlin, Tegel vaccination centers (pictured), which only offer AstraZeneca jabs, say 200 people meet the 3,800 daily appointments

In Berlin, Tegel vaccination centers (pictured), which only offer AstraZeneca jabs, say 200 people meet the 3,800 daily appointments

He told Tageepiegel: ‘I will not leave tens of thousands of doses lying around on our shelves while millions of people across the country wait to be vaccinated. ”

ALSO READ  Teachers go on strike in France where classrooms have remained open

German Health Minister Jens Spahn also backed the coup, saying it was a ‘privilege’ to be offered an injection with the ‘safe and effective’ British vaccine.

Other countries, including Spain, Hungary, Sweden and Norway, have also suggested not to kick anyone over 65.

Scientists admit that there is a lack of data to definitively prove that the vaccine works for the elderly, but the data they have suggests that it does not affect them less than the younger ones, in whom there is evidence that it warns Covid-19.

Boris Johnson had previously said he was not concerned with the European countries’ decision, adding that the UK’s main regulator had ‘made it clear’ that the shot was’ very good and efficient ‘ .

The problem that European countries raised with the study is that the vaccine has only been tested on 660 people over the age of 65 in the results published so far.

Publicity

.

LEAVE A REPLY

Please enter your comment!
Please enter your name here